Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.
Roel G W VerhaakVineet BafnaPaul S MischelPublished in: Nature reviews. Cancer (2019)
Recent reports have demonstrated that oncogene amplification on extrachromosomal DNA (ecDNA) is a frequent event in cancer, providing new momentum to explore a phenomenon first discovered several decades ago. The direct consequence of ecDNA gains in these cases is an increase in DNA copy number of the oncogenes residing on the extrachromosomal element. A secondary effect, perhaps even more important, is that the unequal segregation of ecDNA from a parental tumour cell to offspring cells rapidly increases tumour heterogeneity, thus providing the tumour with an additional array of responses to microenvironment-induced and therapy-induced stress factors and perhaps providing an evolutionary advantage. This Perspectives article discusses the current knowledge and potential implications of oncogene amplification on ecDNA in cancer.
Keyphrases
- nucleic acid
- copy number
- papillary thyroid
- mitochondrial dna
- high glucose
- single cell
- genome wide
- circulating tumor
- diabetic rats
- squamous cell
- induced apoptosis
- stem cells
- cell free
- healthcare
- single molecule
- drug induced
- cell therapy
- dna methylation
- high resolution
- endothelial cells
- cell cycle arrest
- label free
- high fat diet
- mesenchymal stem cells
- oxidative stress
- type diabetes
- metabolic syndrome
- adipose tissue
- endoplasmic reticulum stress
- gene expression
- heat stress
- insulin resistance
- human health
- skeletal muscle